Amol Akhade: Summary of Studies in 2L and Beyond in Metastatic NSCLC
Amol Akhade/hiranandanihospital.org

Amol Akhade: Summary of Studies in 2L and Beyond in Metastatic NSCLC

Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X:

“Nice slide to show summary of studies in 2L and beyond in metastatic NSCLC With egfr mutations.

Money slide from ELCC26

Amol Akhade

Other articles featuring Amol Akhade on OncoDaily.